Vocal Biomarkers Market Report 2026

Vocal Biomarkers Market Overview

• Vocal Biomarkers market size has reached to $3.35 billion in 2025 • Expected to grow to $7.41 billion in 2030 at a compound annual growth rate (CAGR) of 16.8% • Growth Driver: Rising Neurological And Psychological Disorders Driving The Voice Biomarkers Market Growth • Market Trend: Advancements in Vocal Biomarkers Sonde Health's Cognitive Fitness Tracker Launch • North America was the largest region in 2025.

What Is Covered Under Vocal Biomarkers Market?

Vocal biomarkers are measurable features of the voice that can provide insights into an individual's health and well-being. These biomarkers are derived from the analysis of vocal attributes such as pitch, tone, rhythm, volume, and speech patterns. They can be used to detect, monitor, and predict various health conditions, including mental health disorders, neurological diseases, and respiratory conditions. The main types of vocal biomarkers are frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, and others. Frequency in vocal biomarkers refers to the rate at which sound waves vibrate, which can provide insights into a person's health and emotional state. They are used in various applications to ensure proper temperature control and monitoring. They are utilized across various indications, such as psychiatric disorders, neurological disorders, respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), and others. They cater to diverse consumers including children, newborns, and adults. End users of vocal biomarkers include hospitals, clinics, academic institutions, research facilities, and others.

What Is The Vocal Biomarkers Market Growth Forecast?

The vocal biomarkers market size is expected to see rapid growth in the next few years. It will grow to $7.41 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing clinical validation of vocal biomarkers, rising integration with wearable health platforms, expansion of ai-powered diagnostics, growing demand for non-invasive monitoring solutions, increasing regulatory acceptance of digital biomarkers. Major trends in the forecast period include increasing use of AI-driven voice analysis platforms, rising adoption of remote health monitoring tools, growing integration of vocal biomarkers in mental health assessment, expansion of voice-based diagnostic applications, enhanced focus on continuous patient monitoring.

Global Vocal Biomarkers Market Segmentation

1) By Type: Frequency, Amplitude, Error Rate, Vocal Rise Or Fall Time, Phonation Time, Voice Tremor, Pitch, Other Types 2) By Indications: Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Other Indications 3) By Consumer: Children And Newborns, Adults 4) By End Users: Hospitals And Clinics, Academic, Research, Other End-Users Subsegments: 1) By Frequency: Fundamental Frequency (Pitch), Formant Frequencies 2) By Amplitude: Intensity Levels, Amplitude Variation 3) By Error Rate: Phonemic Errors, Prosodic Errors 4) By Vocal Rise Or Fall Time: Rise Time Slope, Fall Time Slope 5) By Phonation Time: Sustained Phonation Duration, Phonation Intervals 6) By Voice Tremor: Frequency Modulation Tremor, Amplitude Modulation Tremor 7) By Pitch: Mean Pitch, Pitch Variability 8) By Other Types: Speech Rate, Jitter, Shimmer

What Is The Driver Of The Vocal Biomarkers Market?

The rising cases of neurological and psychological disorders are expected to propel the growth of the voice biomarkers market going forward. Neurological disorders are medical conditions affecting the nervous system, whereas psychological disorders are conditions that impact mood, thinking, and behavior. The increasing cases of neurological and psychological disorders can be attributed to factors such as increasing stress, aging populations, lifestyle changes, and greater awareness and diagnosis capabilities. Neurological and psychological disorders use voice biomarkers to non-invasively detect and monitor disease-specific changes in speech patterns, pitch, and rhythm, providing valuable insights into the presence and progression of these conditions. For instance, in April 2024, according to the data published by alzheimers.gov, a US-based Department of Health and Human Services (HHS), more than 6 million Americans aged 65 and older are living with Alzheimer’s disease in 2024, and it is predicted that this number will increase to more than 13 million people by 2060. Therefore, the rising cases of neurological and psychological disorders are driving the growth of the voice biomarkers market.

Key Players In The Global Vocal Biomarkers Market

Major companies operating in the vocal biomarkers market are Beyond Verbal, AudEERING, Sonde Health Inc., Kintsugi Health, Ellipsis Health, Canary Speech, Vocalis Health, EVOCAL Health, Cogito Corporation, ConversationHealth, Veritone Inc., Cambridge Cognition Ltd., Neurotrack Technologies Inc., Winterlight Labs, Aural Analytics, PeakProfiling, Mindstrong Health, Sonic Cloud Health, NeuraMetrix, Aiva Health, Modality AI, VoiceSense, VoxMetrix

Global Vocal Biomarkers Market Trends and Insights

Major companies operating in the vocal biomarkers market are focusing on developing advanced technology, such as Monitor Vocal Biomarkers, to enhance the accuracy of disease detection, improve patient monitoring, and enable early intervention for various health conditions. Monitor Vocal Biomarkers refers to the use of voice analysis to identify physiological and psychological health indicators. For instance, in November 2024, Sonde Health, a US-based digital health company, launched Sonde Cognitive Fitness, a voice-based cognitive fitness tracker designed to monitor cognitive effort in real time. The tracker utilizes voice samples collected through most smart devices, analyzing vocal biomarkers to assess cognitive effort.

What Are Latest Mergers And Acquisitions In The Vocal Biomarkers Market?

In January 2023, Cambridge Cognition Ltd., a UK-based neuroscience technology company, acquired Winterlight Labs for approximately $0.0086 billion. This acquisition solidifies Cambridge Cognition's position as a leader in the vocal biomarker market, allowing the company to capitalize on the significant growth potential in this space by offering a comprehensive suite of voice-based solutions for clinical research and healthcare applications. Winterlight Labs is a Canada-based firm specializing in vocal biomarkers for assessing cognitive and mental health conditions.

Regional Outlook

North America was the largest region in the vocal biomarkers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vocal Biomarkers Market?

The vocal biomarkers market consists of revenues earned by entities by providing services such as diagnostic and monitoring services and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vocal biomarkers market also includes sales of specialized recording devices, sensors, and integrated systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vocal Biomarkers Market Report 2026?

The vocal biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vocal biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.